---
schema_version: "secwatch.filing_event.v1"
accession: "0001213900-24-080812"
form_type: "8-K"
ticker: "ORMP"
cik: "0001176309"
company_name: "ORAMED PHARMACEUTICALS INC."
filed_at: "2024-09-23T23:59:59+00:00"
generated_at: "2026-05-31T02:17:19.192052+00:00"
event_type: "other_material"
sentiment: "neutral"
materiality_score: 0.6
calibrated_materiality_score: 0.6
confidence: "high"
source: SEC EDGAR
---

# Oramed & Scilex amend note: $2M prepayment, warrant exercise, liquidity waiver

## Summary
- Scilex pays Oramed $2M Sept 23: $1.7M to March 2025 amort, $300K buys back 4M $11.50 warrants.
- Oramed can immediately exercise CS-5 Warrant for up to 1,062,500 Scilex shares; remaining half exercisable on original date.
- Minimum Liquidity covenant under Note reduced to $0 from Sept 19, 2024 until Maturity (March 21, 2025).
- $20M amortization payment due Sept 23, 2024 extended to Sept 30, 2024 without default.

## SEC filing metadata
- accession: 0001213900-24-080812
- form_type: 8-K
- ticker: ORMP
- cik: 0001176309
- company_name: ORAMED PHARMACEUTICALS INC.
- filed_at: 2024-09-23T23:59:59+00:00
- event_type: other_material
- sentiment: neutral
- materiality_score: 0.6
- calibrated_materiality_score: 0.6
- confidence: high
- sec_items: 8.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1176309/000121390024080812/0001213900-24-080812-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1176309/000121390024080812/ea0215344-8k_oramed.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001213900-24-080812
- JSON: https://secwatch.observer/filing/0001213900-24-080812.json
- Plain text: https://secwatch.observer/filing/0001213900-24-080812.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.